Natural Product: NPC478328

Natural Product IDNPC478328
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
UNJSTVJOOQEGSQ-MZXODVADSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 15240820
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey UNJSTVJOOQEGSQ-MZXODVADSA-N
Standard InCHI InChI=1S/C47H51NO14/c1-25-31(60-43(56)37(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,39(53)36(51)34(25)44(47,4)5)32(59-26(2)49)22-33-46(38,24-58-33)62-27(3)50/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
SMILES CC1=C2[C@H](C(=O)[C@]3(C)[C@H](C[C@@H]4[C@@](CO4)([C@H]3[C@@H]([C@](C[C@@H]1OC(=O)[C@@H]([C@H](c1ccccc1)N=C(c1ccccc1)O)O)(C2(C)C)O)OC(=O)c1ccccc1)OC(=O)C)OC(=O)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   853.33 Volume:   853.449
?
Van der Waals volume.
Dense:   1.0 LogP:   2.693
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.539
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.137
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   14.0 Rigid Bonds:   44.0
TPSA:   224.78
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   4.0 Rings:   7.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.073 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.136 Fsp3:   0.447
MCE-18:   175.882
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.951 Fluc inhibitor:   0.009
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.048
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.411
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.011 Promiscuous compounds:   0.058

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.549 MDCK Permeability:   -4.934
Pgp-inhibitor:   0.419 Pgp-substrate:   1.0
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.982 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   1.0
Plasma Protein Binding (PPB):   95.234% Volume Distribution (VD):   -0.107
Fu: 3.507%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.0
BSEP inhibitor:   0.917

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.178
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.999
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.054 Half-life (T1/2):  2.592

ADMET: Toxicity

hERG Blockers:  0.023 hERG Blockers (10um):  0.117
Human Hepatotoxicity (H-HT):  0.976 Drug-induced Liver Injury (DILI):  0.993
AMES Toxicity:  0.724 Rat Oral Acute Toxicity:  0.495
Maximum Recommended Daily Dose:  0.979 Skin Sensitization:  1.0
Carcinogencity:  0.031 Eye Corrosion:  0.0
Eye Irritation:  0.002 Respiratory Toxicity:  0.071
Drug-induced Neurotoxicity:  0.975 Ototoxicity:  0.811
Hematotoxicity:  0.572 Drug-induced Nephrotoxicity:  0.986
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.18
A549 Cytotoxicity:  0.787 Hek293 Cytotoxicity:  0.619
BCF:   0.539
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.366
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.126
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.329
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.jarmap.2018.11.004]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/S0168-9452(00)00306-X]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. DOI[10.1021/np990201k]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota Needles n.a. n.a. PMID[11325226]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO13290 Taxus canadensis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 = 10.0 nM PMID[11325226]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC478328 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.86 High Similarity NPC289383
0.8144 Intermediate Similarity NPC321072
0.8144 Intermediate Similarity NPC215892
0.8144 Intermediate Similarity NPC242662
0.7339 Intermediate Similarity NPC479186
0.7207 Intermediate Similarity NPC472375
0.7156 Intermediate Similarity NPC116862
0.7087 Intermediate Similarity NPC327699
0.7019 Intermediate Similarity NPC208553
0.7019 Intermediate Similarity NPC181964
0.7019 Intermediate Similarity NPC307628
0.7019 Intermediate Similarity NPC191193
0.6923 Remote Similarity NPC102167
0.6923 Remote Similarity NPC473490
0.6923 Remote Similarity NPC488127
0.6857 Remote Similarity NPC473558
0.6857 Remote Similarity NPC453583
0.6792 Remote Similarity NPC471754
0.6792 Remote Similarity NPC479183
0.6792 Remote Similarity NPC479181
0.6404 Remote Similarity NPC472392
0.6293 Remote Similarity NPC472391
0.6293 Remote Similarity NPC479173
0.6102 Remote Similarity NPC479185
0.6036 Remote Similarity NPC33372
0.6036 Remote Similarity NPC67246
0.6 Remote Similarity NPC479184
0.5982 Remote Similarity NPC478329
0.5946 Remote Similarity NPC471623
0.5946 Remote Similarity NPC317882
0.5909 Remote Similarity NPC473300
0.5893 Remote Similarity NPC324251
0.5893 Remote Similarity NPC206211
0.5841 Remote Similarity NPC487360
0.5841 Remote Similarity NPC479182
0.5841 Remote Similarity NPC479180
0.5841 Remote Similarity NPC471629
0.5841 Remote Similarity NPC306001
0.5804 Remote Similarity NPC453588
0.5776 Remote Similarity NPC487361
0.5739 Remote Similarity NPC275170
0.569 Remote Similarity NPC486061
0.569 Remote Similarity NPC486060
0.5259 Remote Similarity NPC603171
0.5096 Remote Similarity NPC605573
0.5083 Remote Similarity NPC471606
0.5049 Remote Similarity NPC38696
0.5032 Remote Similarity NPC488128

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478328 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7019 Intermediate Similarity NPD8485 Phase 4
0.6923 Remote Similarity NPD8360 Approved
0.6923 Remote Similarity NPD8361 Phase 4
0.6698 Remote Similarity NPD8435 Phase 4
0.6637 Remote Similarity NPD8404 Phase 2
0.6306 Remote Similarity NPD8486 Phase 1
0.6106 Remote Similarity NPD8434 Phase 2
0.6 Remote Similarity NPD8424 Phase 3
0.525 Remote Similarity NPD8470 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data